Santen Pharmaceutical (SNPHY) Short Interest Ratio & Short Volume $12.02 +0.18 (+1.52%) (As of 11/1/2024 05:44 PM ET) Add Compare Share Share Short Interest Stock AnalysisChartFinancialsSEC FilingsShort Interest Santen Pharmaceutical Short Interest DataSanten Pharmaceutical (SNPHY) has a short interest of 700 shares. This marks a -12.50% decrease in short interest from the previous month. The short interest ratio (days to cover) is 0.3, indicating that it would take 0.3 days of the average trading volume of 6,430 shares to cover all short positions.Current Short Interest700 sharesPrevious Short Interest800 sharesChange Vs. Previous Month-12.50%Dollar Volume Sold Short$8,442.00Short Interest Ratio0.3 Days to CoverLast Record DateOctober 15, 2024Today's Trading Volume988 sharesAverage Trading Volume6,430 sharesToday's Volume Vs. Average15% Short Selling Santen Pharmaceutical? Sign up to receive the latest short interest report for Santen Pharmaceutical and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartSNPHY Short Interest Over TimeSNPHY Days to Cover Over TimeSNPHY Percentage of Float Shorted Over Time Ad Timothy SykesCountdown to the biggest trade of my 25 yr careerTim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why Santen Pharmaceutical Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 10/15/2024700 shares $8,442.00 -12.5%N/A0.3 $12.06 9/30/2024800 shares $10,124.00 -57.9%N/A0.1 $12.66 9/15/20241,900 shares $24,348.50 -17.4%N/A0.5 $12.82 8/31/20242,300 shares $28,508.50 +4.6%N/A1 $12.40 8/15/20242,200 shares $26,554.00 +15.8%N/A0.1 $12.07 7/31/20241,900 shares $22,325.00 -24.0%N/A0 $11.75 Get the Latest News and Ratings for SNPHY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Santen Pharmaceutical and its competitors with MarketBeat's FREE daily newsletter. 7/15/20242,500 shares $28,175.00 -3.9%N/A1.9 $11.27 6/30/20242,600 shares $26,520.00 -10.3%N/A0.2 $10.20 6/15/20242,900 shares $29,717.75 +383.3%N/A0.8 $10.25 5/31/2024600 shares $6,160.20 No ChangeN/A0.3 $10.27 4/30/2024100 shares $994.00 No ChangeN/A0 $9.94 4/15/2024100 shares $912.00 No ChangeN/A0 $9.12 3/31/2024100 shares $975.00 No ChangeN/A0.1 $9.75 3/15/2024100 shares $982.42 -99.5%N/A0 $9.82 2/29/202420,800 shares $204,464.00 +20,700.0%N/A0.7 $9.83 2/15/2024100 shares $1,001.00 No ChangeN/A0 $10.01 1/15/2024100 shares $1,014.00 No ChangeN/A0.1 $10.14 11/30/2023900 shares $8,595.45 +80.0%N/A0.4 $9.55 11/15/2023500 shares $4,490.00 +400.0%N/A0.1 $8.98 10/31/2023100 shares $868.50 -85.7%N/A0 $8.69 10/15/2023700 shares $6,204.45 -41.7%N/A0.3 $8.86 9/30/20231,200 shares $10,944.00 -64.7%N/A0.3 $9.12 9/15/20233,400 shares $32,878.00 -30.6%N/A2.1 $9.67 8/31/20234,900 shares $45,300.50 +36.1%N/A1.5 $9.25 8/15/20233,600 shares $33,588.00 -52.6%N/A0.4 $9.33 7/31/20237,600 shares $65,664.00 +216.7%N/A1.4 $8.64 7/15/20232,400 shares $20,040.00 +242.9%N/A0.3 $8.35 6/30/2023700 shares $5,908.00 +16.7%N/A0 $8.44 6/15/2023600 shares $5,100.00 +100.0%N/A0.1 $8.50 5/31/2023300 shares $2,742.00 -25.0%N/A0.2 $9.14 5/15/2023400 shares $3,624.00 No ChangeN/A0.2 $9.06 4/15/2023400 shares $3,296.00 +100.0%N/A0.1 $8.24 3/31/2023200 shares $1,694.00 -60.0%N/A0 $8.47 3/15/2023500 shares $3,810.00 No ChangeN/A0.1 $7.62 2/15/2023100 shares $739.00 -90.0%N/A0 $7.39 1/31/20231,000 shares $7,710.00 No ChangeN/A0.2 $7.71 12/30/2022700 shares $5,624.50 -58.8%N/A0.1 $8.04 12/15/20221,700 shares $13,642.50 -74.6%N/A0.2 $8.03 11/30/20226,700 shares $53,600.00 +86.1%N/A0.4 $8.00 11/15/20223,600 shares $27,468.00 +12.5%N/A0.1 $7.63Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why 10/31/20223,200 shares $21,840.00 -94.0%N/A0.1 $6.83 10/15/202253,100 shares $348,336.00 +517.4%N/A0.9 $6.56 9/30/20228,600 shares $58,222.00 +207.1%N/A0.1 $6.77 9/15/20222,800 shares $18,760.00 -85.6%N/A0 $6.70 8/31/202219,500 shares $139,230.00 +236.2%N/A0.3 $7.14 8/15/20225,800 shares $45,396.60 +5,700.0%N/A0.2 $7.83 7/31/2022100 shares $801.50 No ChangeN/A0 $8.02 6/15/2022400 shares $2,916.00 -90.9%N/A0 $7.29 5/31/20224,400 shares $35,310.00 -63.3%N/A0 $8.03 5/15/202212,000 shares $95,520.00 +823.1%N/A0 $7.96 4/30/20221,300 shares $10,517.00 -38.1%N/A0 $8.09 4/15/20222,100 shares $18,270.00 -92.0%N/A0 $8.70 3/31/202226,300 shares $262,474.00 +87.9%N/A0.3 $9.98 3/15/202214,000 shares $152,600.00 -8.5%N/A0.1 $10.90 2/28/202215,300 shares $173,349.00 -26.4%N/A0.1 $11.33 2/15/202220,800 shares $236,496.00 +300.0%N/A0.1 $11.37 1/31/20225,200 shares $58,812.00 +1,200.0%N/A0 $11.31 1/15/2022400 shares $4,864.00 -98.2%N/A0 $12.16 12/31/202121,600 shares $262,980.00 No ChangeN/A0.1 $12.18 11/30/20211,800 shares $23,670.00 -85.9%N/A0 $13.15 11/15/202112,800 shares $178,412.80 +17.4%N/A0.3 $13.94 10/29/202110,900 shares $153,690.00 +10,800.0%N/A0.2 $14.10 10/15/2021100 shares $1,378.00 -98.4%N/A0 $13.78 9/30/20216,400 shares $90,016.00 +52.4%N/A0.2 $14.07 9/15/20214,200 shares $63,798.00 -8.7%N/A0.2 $15.19 8/31/20214,600 shares $69,368.00 -82.4%N/A0 $15.08 8/13/202126,100 shares $389,673.00 -29.3%N/A0.5 $14.93 7/30/202136,900 shares $498,519.00 +738.6%N/A0.6 $13.51 7/15/20214,400 shares $61,908.00 -85.7%N/A0.1 $14.07 6/30/202130,800 shares $425,964.00 -18.5%N/A0.5 $13.83 6/15/202137,800 shares $526,176.00 +384.6%N/A0.3 $13.92 5/28/20217,800 shares $103,896.00 +136.4%N/A0.1 $13.32 5/14/20213,300 shares $44,253.00 -89.2%N/A0 $13.41 4/30/202130,500 shares $393,145.00 -12.6%N/A0.3 $12.89 4/15/202134,900 shares $466,613.00 -44.4%N/A0.2 $13.37 3/31/202162,800 shares $869,780.00 +784.5%N/A0.5 $13.85 3/15/20217,100 shares $96,986.00 -27.6%N/A0.1 $13.66 2/26/20219,800 shares $137,788.00 +38.0%N/A0.1 $14.06 2/12/20217,100 shares $111,399.00 -70.7%N/A0.1 $15.69 1/29/202124,200 shares $400,026.00 +414.9%N/A0.5 $16.53 12/31/202013,200 shares $213,048.00 No ChangeN/A0.2 $16.14 11/30/20203,800 shares $64,284.60 -85.7%N/A0.1 $16.92 11/15/202026,600 shares $434,577.50 +786.7%N/A0.6 $16.34 10/30/20203,000 shares $55,530.00 +66.7%N/A0.2 $18.51 10/15/20201,800 shares $35,928.00 -86.4%N/A0 $19.96 9/30/202013,200 shares $271,260.00 -5.7%N/A1.1 $20.55 9/15/202014,000 shares $276,220.00 +225.6%N/A0.5 $19.73 8/31/20204,300 shares $81,958.00 -76.5%N/A0.2 $19.06 8/14/202018,300 shares $342,235.62 +16.6%N/A0.5 $18.70 7/31/202015,700 shares $263,775.70 +31.9%N/A0.5 $16.80Tim Sykes’ Urgent Trade Alert: “Make this move now” (Ad)Tim Sykes - the world’s most apolitical Millionaire trader - just sat down for an urgent election interview… Breaking down the ONE MOVE you must make before the November 5th election to set yourself up for a prosperous 2025.Click here to see the surprising reason why 7/15/202011,900 shares $212,534.00 -25.6%N/A0.5 $17.86 6/30/202016,000 shares $294,720.00 +233.3%N/A0.7 $18.42 6/15/20204,800 shares $89,205.60 -65.0%N/A0.2 $18.58 5/29/202013,700 shares $252,011.50 -22.6%N/A0.4 $18.40 5/15/202017,700 shares $313,520.10 +88.3%N/A0.4 $17.71 4/30/20209,400 shares $165,534.00 -40.1%N/A0.1 $17.61 4/15/202015,700 shares $273,337.00 -50.2%N/A0.3 $17.41 3/31/202031,500 shares $535,185.00 +416.4%N/A0.4 $16.99 3/13/20206,100 shares $84,790.00 -72.3%N/A0.1 $13.90 2/28/202022,000 shares $352,660.00 +168.3%N/A0.4 $16.03 2/14/20208,200 shares $130,380.00 -48.4%N/A0.2 $15.90 1/31/202015,900 shares $297,648.00 +169.5%N/A1.5 $18.72 1/15/20205,900 shares $115,728.50 +156.5%N/A0.7 $19.62 12/31/20192,300 shares $44,689.00 +27.8%N/A0.2 $19.43 SNPHY Short Interest - Frequently Asked Questions What is Santen Pharmaceutical's current short interest? Short interest is the volume of Santen Pharmaceutical shares that have been sold short but have not yet been covered or closed out. As of October 15th, investors have sold 700 shares of SNPHY short. Learn More on Santen Pharmaceutical's current short interest. Is Santen Pharmaceutical's short interest increasing or decreasing? Santen Pharmaceutical saw a decline in short interest in the month of October. As of October 15th, there was short interest totaling 700 shares, a decline of 12.5% from the previous total of 800 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Santen Pharmaceutical's short interest compare to its competitors? Here is how the short interest of companies in the sector of "medical" compare to Santen Pharmaceutical: Chugai Pharmaceutical Co., Ltd. (0.01%), Bayer Aktiengesellschaft (0.00%), Astellas Pharma Inc. (0.00%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: Charter Communications, Inc. ($4.14 billion), AppLovin Co. ($3.15 billion), Paychex, Inc. ($2.69 billion), Nu Holdings Ltd. ($2.48 billion), Cencora, Inc. ($2.24 billion), International Paper ($2.04 billion), Tractor Supply ($1.96 billion), Coinbase Global, Inc. ($1.93 billion), Moderna, Inc. ($1.91 billion), and SoFi Technologies, Inc. ($1.84 billion). View all of the most shorted stocks. What does it mean to sell short Santen Pharmaceutical stock? Short selling SNPHY is an investing strategy that aims to generate trading profit from Santen Pharmaceutical as its price is falling. SNPHY shares are trading up $0.18 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Santen Pharmaceutical? A short squeeze for Santen Pharmaceutical occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of SNPHY, which in turn drives the price of the stock up even further. How often is Santen Pharmaceutical's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including SNPHY, twice per month. The most recent reporting period available is October, 15 2024. More Short Interest Resources from MarketBeat Related Companies AstraZeneca Short Interest Daiichi Sankyo Short Interest JCR Pharmaceuticals Short Interest Kyowa Kirin Short Interest Mayne Pharma Group Short Interest Ono Pharmaceutical Short Interest Orion Oyj Short Interest Otsuka Short Interest Otsuka Short Interest Roche Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (OTCMKTS:SNPHY) was last updated on 11/2/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | SponsoredEx WH Advisor Who Predicted Biden Leaving Race Makes Startling New PredictionFormer advisor to the CIA, the Pentagon and the White House Jim Rickards went on multiple TV news programs… ...Paradigm Press | SponsoredSell NVDA Now?Guess who's selling NVDA next The most successful hedge fund in history quietly sold 500,000 shares. Here's...Chaikin Analytics | SponsoredMarket "Famine" ComingMarket Wizard Larry Benedict accurately predicted that all indexes would be negative in 2022... He predicte...Opportunistic Trader | SponsoredThe centerpiece of Trump’s crypto’s masterplan …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin...Weiss Ratings | SponsoredHow Will You Survive A Post Election Retirement Heist?The clock is ticking, and your life savings are in an extremely vulnerable position. We are a few days away...American Hartford Gold Group | SponsoredBlackrock’s Sending THIS Crypto Higher on PurposeIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredI was wrong. Dead wrong. I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Santen Pharmaceutical Co., Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share Santen Pharmaceutical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
